Molecular targets versus models for new antiepileptic drug discovery

This publication has 22 references indexed in Scilit:

• Novel Cyclopropyl β-Amino Acid Analogues of Pregabalin and Gabapentin That Target the α₂-δ Protein
  Journal of Medicinal Chemistry, 2005
• The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
  Nature Medicine, 2004
• The neurobiology of antiepileptic drugs
  Nature Reviews Neuroscience, 2004
• The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
  Proceedings of the National Academy of Sciences, 2004
• A Pooled Analysis of 2 Placebo-Controlled 18-Month Trials of Lamotrigine and Lithium Maintenance in Bipolar I Disorder
  The Journal of Clinical Psychiatry, 2004
• Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons
  Journal of Neuroscience, 2003
• Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
  Epilepsia, 2001
• Do we need any more new antiepileptic drugs?
  Epilepsy Research, 2001
• SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
  Neuron, 1999
• [3H]Batrachotoxinin A 20.alpha.-benzoate binding to voltage-sensitive sodium channels: a rapid and quanitative assay for local anesthetic activity in a variety of drugs
  Journal of Medicinal Chemistry, 1985